Skip to main content
. 2022 Jun 1;12:9135. doi: 10.1038/s41598-022-13124-1

Table 3.

Comparative summary of the Experiment-3 in vitro inhibition kinetics1 of GH5-tCel5A1, the heat-treated GH5-tCel5A1 and GH5-p4818Cel5_2A under the intestinal trypsin (74 U/mL) condition obtained through the Eadie-Hofstee linear regression analyses.

Item Inhibition kinetic parameter estimates
Imax 2 Imin 3 Ic 4 IC50 5
Cellulase activity (nmol/mg protein·min)
GH5-tCel5A1 12.48 ±2.41 0.68 ±0.25 13.16 ±2.41 1.64 ±0.09
Heated GH5-tCel5A1 3.26 ±1.47 1.92 ±0.35 5.17 ±1.47 1.32 ±0.09
GH5-p4818Cel5_2A 69.98 ±2.56 9.76 ±1.16 79.74 ±2.56 1.20 ±0.05
Relative cellulase activity (% of the control)6
GH5-tCel5A1 94.83±18.29 5.17±1.90 100.00 ±18.29 1.64 ±0.09
Heated GH5-tCel5A1 87.39 ±9.68 12.60 ±2.32 100.00 ±9.68 1.32 ±0.09
GH5-p4818Cel5_2A 87.76 ±3.21 12.24 ±1.45 100.00 ±3.21 1.20 ±0.05

1Values are parameter estimates or means ± SE (n = 72) obtained through the Eadie-Hofstee regression linear analyses, representing the inhibition kinetic parameter estimates obtained from the three intestinal trypsin (74 U/mL) inhibition experiments with 4 replicates per time point in each experiment, as shown in Figs. 12, 13, 14.

2 Imax is the maximal magnitude of inhibition in the cellulase activity (nmol/mg protein·min or % of the control, Ic; means ± SE, n = 12) calculated according to Eq. (2).

3 Imin is the minimal residual cellulase activity (nmol/mg protein·min or % of the control, parameter estimate ± SE, n = 72) under the intestinal trypsin (74 U/mL) inhibition condition obtained from Eq. (1).

4 Ic is the mean cellulase activity of the control group (nmol/mg protein·min or % of the control Ic; means ± SE, n = 12).

5 IC50 is the incubation time (h, parameter estimate ± SE, n = 72) required to reach the half maximal inhibition of the cellulase activity.

6Relative cellulase activity calculated as percentage (%, means ± SE, n = 12) of the control group (Ic) measured at 0-min exposure to the intestinal trypsin (74 U/mL) incubation.